Skip to main content

Closed

LXRX: Lexicon Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-34.8%

ROIC-9.3%

Financially safe

Stretched

Debt / equity0.28×

Interest coverage-3.0×

Current ratio18.79×

Lexicon Pharmaceuticals, Inc.

LXRXNASDAQ Global Select·USD·Closed

Lexicon Pharmaceuticals, Inc.

LXRXNASDAQ·USD·Closed

$2.31

−1.28%

$2.31

−$0.03 (1.28%)

52W Range

78thpctl

Volume

0.80×avg

Mkt Cap

1.03BUSD

P/E

-32.4TTM

Div Yield

–ann

52W Range

78thpctl

Volume

0.80×avg

Market Cap

1.03BUSD

P/E Ratio

-32.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings